Clinical Trials Sponsored by Guangzhou Pharmaceucal Company Limited

Total 225 results

Lee's Pharmaceutical Limited
Zhaoke (Guangzhou) Pharmaceutical Limited

Completed

Bioequivalence Study of Azilsartan Tablets in Chinese Healthy Volunteers

Bioequivalence of Two Azilsartan Formulations

Hong Kong
Changzhou LungHealth Medtech Company Limited

Unknown

Transbronchial Lung Biopsy Guided by ENB

Lung Lesion(s) Requiring Evaluation

China
Hanmi Pharmaceutical Company Limited

Not yet recruiting

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Not yet recruiting

A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients

Hypertension
Hanmi Pharmaceutical Company Limited

Not yet recruiting

A Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus

Obesity
Hanmi Pharmaceutical Company Limited

Recruiting

Study to Evaluate Efficacy, Safety and Tolerability of HM15211 in Subjects

NASH - Nonalcoholic Steatohepatitis

Korea, Republic of, United States
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2201 and Co-administration of Each Component in Healty Male Volunteers

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension Patients

Hypertension

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Phase 1 PK Study to Assess Safety, PK, Tolerability of HM15912 in Subjects With Renal Impairment and Normal Renal Function

Renal Impairment

United States
Hanmi Pharmaceutical Company Limited

Completed

Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients

Hypertension

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients

Hypertension

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients

Hypertension

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Active, not recruiting

HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors

Metastatic Solid Tumor | Locally Advanced Solid Tumor

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis

Gastritis

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension (HM_APOLLO)

Hypertension

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects.

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

An Observational Study Assessing Effects in Patients With Combination Therapy With Raloxifene/Cholecalciferol

Osteoporosis

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetics and Anti-tumor Activity of HM95573

Neoplasms

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis

Perennial Allergic Rhinitis

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate the Pharmacokinetics and Safety of HIP1701 in Healthy Subjects

Health, Subjective

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Male Subjects

Heathy Volunteer

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Pharmacokinetics of HCP1305 and Co-administration of HCP0605, HGP0816 in Healthy Male Volunteers

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Unknown

A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211

Obesity

United States
Hanmi Pharmaceutical Company Limited

Completed

Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients

Non Small Cell Lung Cancer

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Clinical Trial on Education Method of Fluterol® Inhalation Inhaler for Asthma Control

Asthma
Hanmi Pharmaceutical Company Limited

Completed

A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A (HM12460A)

Healthy | Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Hanmi Pharmaceutical Company Limited

Unknown

Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus

Type2 Diabetes Mellitus | Type1 Diabetes Mellitus

United States
Hanmi Pharmaceutical Company Limited

Completed

Molar Potency Study of HM12470 in Healthy Subjects

Healthy Subjects

United States
Hanmi Pharmaceutical Company Limited

Completed

Study to Evaluate a Pharmacokinetic of HM61713 in Healthy Male Subjects

Healthy Volunteers

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Trial to Evaluate the Efficacy and Safety of HCP1302

Hypertension | Erectile Dysfunction
Hanmi Pharmaceutical Company Limited

Unknown

Clinical Efficacy and Safety Evaluation of HCP1202 in COPD Patients

Chronic Obstructive Pulmonary Disease
Hanmi Pharmaceutical Company Limited

Completed

Evaluate the Pharmacokinetics and Safety of HCP1306 and Co-administration of HGP0816, HGP1404 in Healthy Male Volunteers

Primary Hypercholesterolemia
Hanmi Pharmaceutical Company Limited

Completed

Investigating the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunteers

Overactive Bladder
Hanmi Pharmaceutical Company Limited

Terminated

Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome

Abdominal Obesity Metabolic Syndrome

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus

Diabetes Mellitus

United States
Hanmi Pharmaceutical Company Limited

Completed

Partial Replicated Crossover Clinical Study to Compare Pharmacokinectic Characteristics of Eperisone Hydrochloride and Aceclofenac With HCP1104 Treatment to Those of Co-administration of Eperisone Hydrochloride 50mg Tablet and Aceclofenac 100mg Tablet in Healthy Adult Male Volunteers

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Study to Evaluate a Pharmacokinetic Drug Interaction Between Eperisone Hydrochloride and Aceclofenac in Healthy Male Subjects

Acute Low Back Pain
Hanmi Pharmaceutical Company Limited

Completed

A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007

Healthy

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Safety and PK of HM10460A (HNK460) in Healthy Adult Japanese and Caucasian Subjects

Healthy

United States
Hanmi Pharmaceutical Company Limited

Completed

A Study of HM11260C in Healthy Male Subject

Healthy
Hanmi Pharmaceutical Company Limited

Unknown

Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A)

Chronic Hepatitis C Virus Genotype I

Mexico
Hanmi Pharmaceutical Company Limited

Completed

Safety, Pharmacokinetic, Pharmacodynamic Study of LAPS-IFNa in Healthy Adult Subjects

Healthy

Netherlands
Hanmi Pharmaceutical Company Limited

Completed

Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 20mg

Diabetes Mellitus

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia

Hypertension | Hyperlipidemia

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Single-dose, 2-way Crossover Open Study to Evaluate the Food Effect on the PK of HCP1201 in Healthy Volunteers

Diabetes Mellitus

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis

Vasomotor Rhinitis

Korea, Republic of
Hanmi Pharmaceutical Company Limited

Completed

Diurnal Variation in Hypertensive Stroke Patients

Stroke | Hypertension

Korea, Republic of

3

Subscribe